Skip to site menu Skip to page content

Daily Newsletter

09 August 2023

Daily Newsletter

09 August 2023

New pathology lab opens at Nepean Hospital

The facility is a key component of the A$1bn redevelopment of Nepean Hospital.

August 09 2023

A pathology laboratory equipped with advanced medical technology has been inaugurated at Nepean Hospital in Kingswood, New South Wales (NSW), Australia.

The laboratory marks a part of a A$29m ($18.99m) investment in healthcare facilities across western Sydney and regional NSW.

The facility is a key component of the A$1bn ($654.76m) redevelopment of Nepean Hospital and was officially opened by NSW Health Minister Ryan Park.

This laboratory is claimed to be among the first to feature advanced chemical pathology analysers in NSW Health Pathology laboratories.

It will conduct common tests such as liver and kidney function assessments, as well as diabetes monitoring.

The expanded facility is said to be 1.5 times bigger than its predecessor, incorporating the latest equipment to improve testing procedures and efficiency.

Nepean Hospital will get new chemical pathology analysers as part of the A$29m ($18.99m) initiative, along with several other facilities in the region, including Auburn, Blacktown, Blue Mountains, Mount Druitt, and Westmead Hospitals.

This investment focuses on automation technology to enhance sample movement and processing in larger laboratories.

Completion of the pathology laboratory enables the commencement of construction for Nepean Hospital's stage two building, which will feature an adult intensive care unit, renal services, medical imaging, and over 100 inpatient beds.

The Nepean Hospital redevelopment is taking place in two stages, with stage one already operational since 2022.

Stage two construction is ongoing and slated for completion in 2026.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close